Hospital Clínic-IDIBAPS is leading a European project to evaluate the efficacy of treatment with the combination of rifaximin, an antibiotic that mo1
Transplant Biomedical, one of the two spin-offs arising from IDIBAPS, will receive a maximum of 2.5 million euros to carry out the clinical phase of1
IDIBAPS researchers have participated in a study that shows how a new experimental drug could curb a wide variety of autoimmune diseases such as ast1
The European Commission has published the Horizon 2020 Monitoring report for 2015. This document includes, among others, the 50 institutions that ha1
Blanca Molins rep el premi Julián García Sánchez de recerca en temes de la visió
Scientists from Salk Institute for Biological Studies showed that One clue to halting or reversing aging lies in the study of cellular reprogramming1
Marc Claret, head of the IDIBAPS Group Neuronal Control of Metabolism, has received a Consolidator Grant from the European Research Council (ERC) to1
On Monday, December 12, Palau Macaya hosted the presentation of the selected projects in the second edition of CaixaImpulse, two of which are from I1
Researchers from Hospital Clínic and IDIBAPS lead an international study in which they have developed a genomic test to predict the response to chemo1
Yesterday the Professional Excellence Prizes 2016 were awarded by the Col·legi de Metges de Barcelona (CoMB) to physicians in recognition to their c1
